Stockreport

ImmunityBio GAAP EPS of -$0.07 beats by $0.04, revenue of $32.06M beats by $0.18M [Seeking Alpha]

ImmunityBio, Inc.  (IBRX) 
PDF Cash Position: $257.8 million in cash, cash equivalents, and marketable securities as of September 30, 2025, up from $153.7 million as of June 30, 2025. More on Immun [Read more]